Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease
Open accessThe DOI matches its Crossref record; 82 of the 83 references it cites were found in a registry or an index.
Abstract
The purpose of this study was to use serial imaging to gain insight into the sequence of pathologic events in Alzheimer's disease, and the clinical features associated with this sequence. We measured change in amyloid deposition over time using serial (11)C Pittsburgh compound B (PIB) positron emission tomography and progression of neurodegeneration using serial structural magnetic resonance imaging. We studied 21 healthy cognitively normal subjects, 32 with amnestic mild cognitive impairment and 8 with Alzheimer's disease. Subjects were drawn from two sources--ongoing longitudinal registries at Mayo Clinic, and the Alzheimer's disease Neuroimaging Initiative (ADNI). All subjects underwent clinical assessments, MRI and PIB studies at two time points, approximately one year apart. PIB retention was quantified in global cortical to cerebellar ratio units and brain atrophy in units of cm(3) by measuring ventricular expansion. The annual change in global PIB retention did not differ by clinical group (P = 0.90), and although small (median 0.042 ratio units/year overall) was greater than zero among all subjects (P < 0.001). Ventricular expansion rates differed by clinical group (P < 0.001) and increased in the following order: cognitively normal (1.3 cm(3)/year) < amnestic mild cognitive impairment (2.5 cm(3)/year) < Alzheimer's disease (7.7 cm(3)/year). Among all subjects there was no correlation between PIB change and concurrent change on CDR-SB (r = -0.01, P = 0.97) but some evidence of a weak correlation with MMSE (r =-0.22, P = 0.09). In contrast, greater rates of ventricular expansion were clearly correlated with worsening concurrent change on CDR-SB (r = 0.42, P < 0.01) and MMSE (r =-0.52, P < 0.01). Our data are consistent with a model of typical late onset Alzheimer's disease that has two main features: (i) dissociation between the rate of amyloid deposition and the rate of neurodegeneration late in life, with amyloid deposition proceeding at a constant slow rate while neurodegeneration accelerates and (ii) clinical symptoms are coupled to neurodegeneration not amyloid deposition. Significant plaque deposition occurs prior to clinical decline. The presence of brain amyloidosis alone is not sufficient to produce cognitive decline, rather, the neurodegenerative component of Alzheimer's disease pathology is the direct substrate of cognitive impairment and the rate of cognitive decline is driven by the rate of neurodegeneration. Neurodegeneration (atrophy on MRI) both precedes and parallels cognitive decline. This model implies a complimentary role for MRI and PIB imaging in Alzheimer's disease, with each reflecting one of the major pathologies, amyloid dysmetabolism and neurodegeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Efforts continue to be placed on the early detection of AD as changes in brain chemistry begin to occur 20 years or more prior to the onset of noticeable cognitive symptoms [137,138,139,140].”
From Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease (2020) · cites this paper as [137]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although these symptoms are new to the individual affected, the brain changes that cause them are thought to begin 20 years or more before symptoms start.”
From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [3]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Studies of non-demented elderly cohorts overall report approximately 20–40% are PIB-positive [67, 68, 71–78].”
From Brain aging, Alzheimer's disease, and mitochondria (2011) · cites this paper as [68]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Tzourio-Mazoyer, N., Landeau, B., Papathanassiou, D., Crivello, F., Etard, O., Delcroix, N., Mazoyer, B., & Joliot, M. (2002) · NeuroImage · doi:10.1006/nimg.2001.0978 · Cited by 16,319 · cited 1×
“The automated anatomic labelling (AAL) atlas (Tzourio-Mazoyer et al., 2002) was modified in-house to contain the following labelled regions of interest: right and left parietal, temporal, prefrontal, primary sensory -motor, orbito frontal, anterior cingulate, posterior cingulate/ precuneus and occipital.”
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)
Hu, R. J. (2003) · Encyclopedia of the Neurological Sciences · doi:10.1016/b0-12-226870-9/01070-4 · Cited by 9,117
Diagnostic and Statistical Manual of Mental Disorders
Siegel, L. J., & Fletcher‐Janzem, E. (2008) · Encyclopedia of Special Education · doi:10.1002/9780470373699.speced0655 · Cited by 8,477
What's wrong with Bonferroni adjustments
Perneger, T. V. (1998) · BMJ · doi:10.1136/bmj.316.7139.1236 · Cited by 5,900
Current concepts in mild cognitive impairment
Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., Rabins, P. V., Ritchie, K., Rossor, M., Thal, L., & Winblad, B. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.1985 · Cited by 4,781
Self-citation
Cited by
Items 801–900 of 1,000
Choi, J. K., Kwon, O. Y., & Lee, S. H. (2024) · Food Science of Animal Resources · doi:10.5851/kosfa.2024.e5 · Cited by 8
Clinical Assessment of Amyloid Imaging in Alzheimer's Disease: A Systematic Review of the Literature
Wahlster, P., Niederländer, C., Kriza, C., Schaller, S., & Kolominsky‐Rabas, P. L. (2013) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000351679 · Cited by 9
Relative contributions of biomarkers in Alzheimer’s disease
Haight, T. J., & Jagust, W. (2012) · Annals of Epidemiology · doi:10.1016/j.annepidem.2012.09.004 · Cited by 9
Cognitive Impairment and Dementias
Khosravi, M., Newberg, A. B., & Alavi, A. A. (2018) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2018.07.005 · Cited by 8
Biopathological Significance of Early-Phase Amyloid Imaging in the Spectrum of Alzheimer’s Disease
Bunai, T., Kakimoto, A., Yoshikawa, E., Terada, T., & Ouchi, Y. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181188 · Cited by 8
A novel transfer learning model for predictive analytics using incomplete multimodality data
Liu, X., Chen, K., Weidman, D. A., Wu, T., Lure, F. Y. M., Li, J., & Initiative, A. D. N. (2020) · IISE Transactions · doi:10.1080/24725854.2020.1798569 · Cited by 8
Gentzsch, C., Chen, X., Spatz, P., Košak, U., Knez, D., Nose, N., Gobec, S., Higuchi, T., & Decker, M. W. (2021) · Molecular Imaging and Biology · doi:10.1007/s11307-021-01584-2 · Cited by 8
Beyond diagnosis: What biomarkers are teaching us about the “bio”logy of Alzheimer disease
Rabinovici, G. D., & Roberson, E. D. (2010) · Annals of Neurology · doi:10.1002/ana.22020 · Cited by 10
Chang, Y., Huang, C., Chen, N.-C., Lin, K., Huang, S., Chang, Y., Hsu, S., Chang, W., Lui, C., Hsu, C.-W., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149056 · Cited by 9
Progression of Atrophy in Alzheimer’s Disease and Related Disorders
Whitwell, J. L. (2010) · Springer eBooks · doi:10.1007/978-1-4614-0785-0_15 · Cited by 8
Fletcher, B. R., & Rapp, P. R. (2012) · Wiley eBooks · doi:10.1002/9781118133880.hop203024 · Cited by 10
Wu, D., Hu, Y., Song, M., & Li, G. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.634948 · Cited by 7
“According to this hypothesis, amyloid beta (Aβ) pathology in the brain is followed by the development of neurofibrillary tau pathology and commences several years before obvious memory loss (Jack et al., 2009).”
BackgroundFazeli, P. L., Hopkins, C., Vance, D. E., Wadley, V. G., Li, P., Turan, B., Bowen, P. G., & Clay, O. J. (2022) · Nursing Research and Reviews · doi:10.2147/nrr.s339200 · Cited by 8
Köse, L. P., & Köse, A. (2024) · ChemistrySelect · doi:10.1002/slct.202400684 · Cited by 7
Raji, C. A., Torosyan, N., & Silverman, D. H. S. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200487 · Cited by 7
Jiménez-Bonilla, J. F., Banzo, I., de Arcocha-Torres, M., Quirce, R., Martínez‐Rodríguez, I., Lavado-Pérez, C., Bravo-Ferrer, Z., Rodríguez‐Rodríguez, E., Sánchez‐Juan, P., & CARRIL, J. M. (2016) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000000569 · Cited by 7
The association between functional connectivity and cognition in older adults
Khasawinah, S., Chuang, Y., Caffo, B. C., Erickson, K. I., Kramer, A. F., & Carlson, M. C. (2017) · Journal of Systems and Integrative Neuroscience · doi:10.15761/jsin.1000164 · Cited by 9
Kim, H., Lee, J., Cheong, E., Chung, S.-E., Jo, S., Shim, W. H., & Hong, Y. J. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666201130094259 · Cited by 8
When Does Alzheimer’s Disease Really Start? The Role of Biomarkers
Lloret, A., Esteve, D., Lloret, M.-Á., Cervera‐Ferri, A., Lopez, B., Nepomuceno, M., & Monllor, P. (2021) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.19305 · Cited by 8
Vassilaki, M. E., Aakre, J. A., Kremers, W. K., Mielke, M. M., Geda, Y. E., Machulda, M. M., Knopman, D. S., Vemuri, P., Lowe, V. J., Jack, C. R., et al. (2022) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000001157 · Cited by 7
Self-citationEstimating the Temporal Evolution of Alzheimer's Disease Pathology with Autopsy Data
Royall, D. R., & Palmer, R. F. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120430 · Cited by 7
Shokouhi, S., Campbell, D. L., Brill, A. B., Gwirtsman, H. E., & Initiative, T. A. D. N. (2016) · Brain Pathology · doi:10.1111/bpa.12399 · Cited by 7
Positron Emission Tomography in Alzheimer Disease
Schmidt, M. E., Matthews, D. C., Andrews, R. D., & Mosconi, L. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-386945-6.00005-6 · Cited by 7
Huang, C., Huang, W., Chen, C., Jhou, Z., Initiative, T. A. D. N., & Lin, C. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00251 · Cited by 8
New Trajectory of Clinical and Biomarker Changes in Sporadic Alzheimer’s Disease
Zhuo, J., Zhang, Y., Liu, Y., Liu, B., Zhou, X. A., Bartlett, P. F., Jiang, T., & Initiative, A. D. N. (2021) · Cerebral Cortex · doi:10.1093/cercor/bhab017 · Cited by 9
Comprehensive overview of Alzheimer's disease utilizing Machine Learning approaches
Kumar, R., & Azad, C. (2024) · Multimedia Tools and Applications · doi:10.1007/s11042-024-19425-z · Cited by 9
Dursun, I. H., Akın, M., Aluçlu, M. U., & Uyar, B. (2025) · Applied Sciences · doi:10.3390/app15168983 · Cited by 6
Molecular Targets in the Rational Design of AD Specific PET Tracers: Tau or Amyloid Aggregates?
Rojo, L. E., Gaspar, P. A., & Maccioni, R. B. (2011) · Current Alzheimer Research · doi:10.2174/156720511796717203 · Cited by 6
Yoshida, K., Hata, Y., Ichimata, S., Tanaka, R., & Nishida, N. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14037 · Cited by 6
Les marqueurs de la maladie d’Alzheimer prodromale
de Souza, L. C., Sarazin, M., Uspenskaya, O., Habert, M., Lamari, F., Lehéricy, S., & Dubois, B. (2012) · Revue Neurologique · doi:10.1016/j.neurol.2012.07.005 · Cited by 6
Hunter, S., & Brayne, C. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.12.015 · Cited by 7
Computing Brain Change over Time
Ridgway, G. R., Leung, K. K., & Ashburner, J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-397025-1.00313-4 · Cited by 7
Mehrnahad, M., Rostami, S., Kimia, F., Kord, R., Taheri, M. S., Rad, H. S., Haghighatkhah, H., Moradi, A., & Valeshabad, A. K. (2020) · The Neuroradiology Journal · doi:10.1177/1971400920937382 · Cited by 6
A Novel Computational Proxy for Characterizing Cognitive Reserve in Alzheimer’s Disease
Zhang, Y., Initiative, A. D. N., Hao, Y., Li, L., Xia, K., & Wu, G. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-201011 · Cited by 7
Chen, N., Yan, N., Liu, C., Ge, Y., Zhang, J., & Meng, F. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.02.002 · Cited by 6
Yoon, C. W., Kang, M., Shin, H. R., Jeon, S., Yang, J. J., Kim, S. T., Noh, Y., Kim, G. H., Kim, Y. J., Kim, Y. J., et al. (2014) · European Journal of Neurology · doi:10.1111/ene.12485 · Cited by 6
Amnestic mild cognitive impairment
Butler, C., & Ahmed, S. (2016) · Cambridge University Press eBooks · doi:10.1017/9781139924771.016 · Cited by 6
Balabanski, L., Serbezov, D., Atanasoska, M., Karachanak-Yankova, S., Hadjidekova, S. P., Nikolova, D. N., Boyanova, O., Staneva, R., Vazharova, R., Михайлова, М., et al. (2021) · Biotechnology & Biotechnological Equipment · doi:10.1080/13102818.2021.1964382 · Cited by 7
O'Sullivan, M. (2009) · Reviews in Clinical Gerontology · doi:10.1017/s0959259809990426 · Cited by 6
Grimmer, T., Drzezga, A. E., & Kurz, A. (2010) · Der Nervenarzt · doi:10.1007/s00115-010-2951-6 · Cited by 7
Microglial Drivers of Alzheimer's Disease Pathology: An Evolution of Diverse Participating States
Kuhn, M. K., & Proctor, E. A. (2024) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.26723 · Cited by 5
Current Methods in Clinical Alzheimer’s Disease Research and Diagnosis
Kodosaki, E., Zetterberg, H., & Heslegrave, A. (2025) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-025-00789-3 · Cited by 6
Michelson, D. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.06.002 · Cited by 5
Petiet, A., & Dhénain, M. (2011) · Current Medical Imaging Formerly Current Medical Imaging Reviews · doi:10.2174/157340511794653496 · Cited by 5
Pillai, J. A., Larvie, M., Chen, J. M., Crawford, A., Cummings, J. L., & Jones, S. E. (2020) · Scientific Reports · doi:10.1038/s41598-020-77503-2 · Cited by 5
Liu, Q. Y., Bingham, E. J., Twine, S. M., Geiger, J. D., & Ghribi, O. (2012) · Journal of Postgenomics Drug & Biomarker Development · doi:10.4172/2153-0769.1000109 · Cited by 5
Linking CSF and cognition in Alzheimer's disease: Reanalysis of clinical data
Guhra, M., Thomas, C., Boedeker, S., Kreisel, S. H., Drießen, M., Beblo, T., Ohrmann, P., & Toepper, M. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2015.11.008 · Cited by 6
Schramm, S. H., Jokisch, M., Jöckel, K., Herring, A., & Keyvani, K. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00945-x · Cited by 5
An international perspective on advanced neuroimaging: cometh the hour or ivory tower?
Ritchie, C. W., Ames, D. J., Burke, J. R., Bustin, J., Connelly, P., Laczó, J., & Portet, F. (2011) · International Psychogeriatrics · doi:10.1017/s1041610211000901 · Cited by 6
Neurodegenerative dementias: From MR Physics lab to assessment room
Bruno, S., Cercignani, M., & Wheeler‐Kingshott, C. A. M. G. (2012) · The European Physical Journal Plus · doi:10.1140/epjp/i2012-12139-2 · Cited by 5
Neuroimaging Findings in Mild Cognitive Impairment
Nobili, F. M., Arnaldi, D., Roccatagliata, L., Chincarini, A., Accardo, J., Picco, A., Ferrara, M., Buschiazzo, A., & Morbelli, S. D. (2014) · Springer eBooks · doi:10.1007/978-3-642-54307-4_12 · Cited by 5
Pais, M. V., Loureiro, J. C., do Vale, V. S., Radanovic, M., Talib, L. L., Stella, F., & Forlenza, O. V. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210144 · Cited by 5
Biomarkers of Alzheimer′s Disease: From Central Nervous System to Periphery?
Mossello, E., Ballini, E., Mello, A. M., Tarantini, F., Simoni, D., Baldasseroni, S., & Marchionni, N. (2010) · International Journal of Alzheimer s Disease · doi:10.4061/2011/342980 · Cited by 6
Retracted: Diagnosis of Alzheimer Disease using Classification Algorithms
Roobini, M. S., & Lakshmi, M. (2020) · International Conference on Intelligent Sustainable Systems (ICISS) · doi:10.1109/iciss49785.2020.9316028 · Cited by 6
RetractedNeuroimaging of Alzheimer’s Disease, Mild Cognitive Impairment, and Other Dementias
Risacher, S. L., & Saykin, A. J. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6373-4_19 · Cited by 5
Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease
Bennett, D. A. (2013) · Neurology · doi:10.1212/01.wnl.0000427396.91304.3d · Cited by 5
MRI Images Analysis Method for Early Stage Alzheimer's Disease DetectionPreprint
Miled, A. B., Yeferny, T., & Rabeh, A. B. (2020) · arXiv (Cornell University) · doi:10.48550/arxiv.2012.00830 · Cited by 5
Amyloid Imaging with AV45 (18F-florbetapir) in a Cognitively Normal AβPP Duplication Carrier
Saint‐Aubert, L., Planton, M., Hannequin, D., Albucher, J., Delisle, M., Payoux, P., Hitzel, A., Viallard, G., Péran, P., Campion, D., et al. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-111598 · Cited by 7
Rauhala, E., Johansson, J. J., Karrasch, M., Eskola, O., Tolvanen, T., Parkkola, R. K., Virtanen, K. A., & Rinne, J. O. (2022) · EJNMMI Research · doi:10.1186/s13550-022-00928-5 · Cited by 4
Mueller, K. D. (2023) · Springer eBooks · doi:10.1007/978-3-031-45190-4_4 · Cited by 5
Anawal, L., M, C. V., Shalavadi, M. H., Teli, S., Madalageri, M., Sadashivanavar, V., Patil, V., Kumbar, S., & Horatti, P. (2024) · Asian Journal of Pharmacy and Technology · doi:10.52711/2231-5713.2024.00033 · Cited by 6
Feunaing, R. T., Yaya, A. J. G., Nyemb, J. N., Bassigue, N. I., Ketsemen, H. L., Henoumont, C., Kandeda, A. K., Venditti, A., Laurent, S., & Talla, E. (2025) · Natural Product Research · doi:10.1080/14786419.2025.2491113 · Cited by 4
Aβ Imaging in Aging, Alzheimer’s Disease and Other Neurodegenerative Conditions
Villemagne, V. L., Fodero‐Tavoletti, M. T., Yates, P. A., Masters, C. L., & Rowe, C. C. (2014) · Springer eBooks · doi:10.1007/978-3-642-54307-4_10 · Cited by 4
Patel, S. K., Restrepo, C., Werden, E., Churilov, L. P., Ekinci, E. I., Srivastava, P., Ramchand, J., Wai, B., Chambers, B. R., O'Callaghan, C. J., et al. (2017) · BMC Endocrine Disorders · doi:10.1186/s12902-017-0173-7 · Cited by 4
Choi, M., Ghammraoui, B., & Badano, A. G. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186451 · Cited by 4
Messner, D. A., Rabins, P. V., Downing, A. C., Irizarry, M. C., Foster, N. L., Naber, J. A., Dabbous, O. H., Fillit, H. M., Gabler, S., Krakauer, R. S., et al. (2019) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2018.42 · Cited by 4
Jiang, H., Esparza, T. J., Kummer, T. T., & Brody, D. L. (2021) · PLoS ONE · doi:10.1371/journal.pone.0259335 · Cited by 4
Neuroimaging Findings in Mild Cognitive Impairment
Massa, F., Bauckneht, M., Peira, E., Lapucci, C., Picco, A., Capitanio, S., Arnaldi, D., Roccatagliata, L., Chincarini, A., & Nobili, F. M. (2020) · Springer eBooks · doi:10.1007/978-3-030-53168-3_12 · Cited by 4
Newberg, A. B., Coble, R., Khosravi, M., & Alavi, A. A. (2022) · PET Clinics · doi:10.1016/j.cpet.2022.03.009 · Cited by 4
Identification of Alzheimer Disease by Using Hybrid Deep Models
Zia, M. A., Saeed, Z., Asghar, N., Majeed, B. J., & Hashim, M. (2022) · Lecture notes on data engineering and communications technologies · doi:10.1007/978-3-031-10388-9_34 · Cited by 4
Cui, L., Zhang, Z., Huang, Y., Xie, F., Guan, Y., Lo, C. Z., Guo, Y., Jiang, J., & Guo, Q. (2023) · Brain Imaging and Behavior · doi:10.1007/s11682-023-00780-8 · Cited by 4
Aine, C. J., Adair, J. C., Knoefel, J. E., Sanfratello, L., & Stephen, J. M. (2014) · Springer eBooks · doi:10.1007/978-3-642-33045-2_31 · Cited by 4
Blood Pressure and Cognitive Outcome
Mackey, R. H., & Kuller, L. H. (2010) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-010-0122-8 · Cited by 4
Neuroprotective effects of vagus nerve stimulation on hippocampal neurons in intractable epilepsy
Chen, N., Zhang, H., Gao, X., Yan, N., Ma, Y., & Yu, C. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.10.005 · Cited by 4
Isn’t amyloid more than just a marker for Alzheimer disease?
Killiany, R. (2009) · Neurology · doi:10.1212/wnl.0b013e3181be020a · Cited by 4
Using Pittsburgh Compound B For Pet Imaging Across the Alzheimer’s Disease Spectrum
Cohen, A. D. (2016) · Technology & Innovation · doi:10.21300/18.1.2016.51 · Cited by 4
Adamo, S. M., Ramirez, J., Holmes, M. F., Gao, F., Zotovic, L., Masellis, M., & Black, S. E. (2020) · medRxiv · doi:10.1101/2020.11.30.20240879 · Cited by 5
Moore, B. D., Levites, Y., Xu, G. M., Hampton, H., Adamo, M. F., Croft, C. L., Futch, H. S., Moran, C., Fromholt, S., Janus, C., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-1040944/v1 · Cited by 7
Zondagh, L. S., Malan, S. F., & Joubert, J. (2024) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2024.106869 · Cited by 3
ACR–ACNM–ASNR–SNMMI Practice Parameter for the Performance of Brain PET/CT Imaging in Dementia
Tu, R. K., Esposito, G., Agarwal, A., Akin, E. A., Catana, C., Chiang, G. C.-Y., Colletti, P. M., Dhingra, J., Kuo, P. H., Franceschi, A. M., et al. (2026) · American Journal of Neuroradiology · doi:10.3174/ajnr.a9105 · Cited by 3
Ewers, M., Insel, P. S., Jagust, W. J., Shaw, L. M. J., Trojanowski, J. Q., Aisen, P. S. S., Petersen, R. C., Schuff, N. W., & Weiner, M. W. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.05.010 · Cited by 3
Self-citationPang, Q., Lee, S., Cho, E. J., & Kim, J.-H. (2023) · Life · doi:10.3390/life13071453 · Cited by 3
Leyton, C. E., Cassidy, B., Villemagne, V. L., Jones, G. R., Kwok, J. B., Rowe, C. C., Ballard, K. J., Piguet, O., & Hodges, J. R. (2015) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2015.09.004 · Cited by 3
alzheimer disease: New Concepts on Its Neurobiology and the Clinical
Jack, C. R., & Cme, O. (2012) · Cited by 3
Self-citationApostolova, L. G., DeKosky, S. T., & Cummings, J. L. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0434-1.00091-8 · Cited by 4
Contributions of oophorectomy and other gynecologic surgeries to cognitive decline and dementia
Crawford, S. L. (2022) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001991 · Cited by 4
Brain Amyloid in Sporadic Young Onset Alzheimer’s Disease
Panegyres, P. K., & Robins, P. D. (2023) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-220110 · Cited by 3
Women at Greater Risk of Alzheimer’s: Way Forward
Ibeachu, C. P. (2023) · Sustainable development goals series · doi:10.1007/978-3-031-34963-8_4 · Cited by 3
Zhang, Y., Dong, M., Li, B.-L., & Sun, G. (2024) · Chaos Solitons & Fractals · doi:10.1016/j.chaos.2024.114867 · Cited by 3
Visual assessments of 11C-Pittsburgh compound-B PET vs. 18F-flutemetamol PET across the age spectrum
Zeydan, B., Johnson, D. R., Schwarz, C. G., Przybelski, S. A., Lesnick, T. G., Senjem, M. L., Kantarci, O. H., Min, H.-K. P., Kemp, B. J., Jack, C. R., et al. (2024) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000001902 · Cited by 3
Self-citationPearson, S. D., Ollendorf, D. A., & Colby, J. A. (2012) · Cited by 6
Cerebral lactate metabolism and memory: Implications for Alzheimer's disease
Harris, R. A. (2017) · Scholarship@Western (Western University) · Cited by 4
Cognition et imagerie cérébrale : contrastes entre vieillissement normal et maladie d’Alzheimer
Sayette, V. D. L., Eustache, F., & Desgranges, B. (2013) · Springer eBooks · doi:10.1007/978-2-8178-0443-9_6 · Cited by 4
The Radiogenomics of Late-onset Alzheimer Disease
Bonham, L. W., Sirkis, D. W., Hess, C. P., Sugrue, L. P., & Yokoyama, J. S. (2019) · Topics in Magnetic Resonance Imaging · doi:10.1097/rmr.0000000000000222 · Cited by 3
Vlegels, N., Ossenkoppele, R., van der Flier, W. M., Koek, H. L., Reijmer, Y. D., Wisse, L. E. M., Biessels, G. J., & Initiative, T. A. D. N. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220024 · Cited by 3
Fazeli, P. L., Hopkins, C., Vance, D. E., Wadley, V. G., Li, P., Turan, B., Wang, D. H., Bowen, P. G., & Clay, O. J. (2023) · Ethnicity and Health · doi:10.1080/13557858.2023.2231669 · Cited by 3
Jasmin, S. B. (2011) · eScholarship@McGill (McGill) · doi:10.82308/52384 · Cited by 3
Tapping into the biology of Alzheimer disease
Knopman, D. S. (2011) · Neurology · doi:10.1212/wnl.0b013e31820af995 · Cited by 3
Self-citationWill CSF analysis become routine in people with memory complaints?
Gauthier, S. G. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70145-0 · Cited by 3
The specificity of amyloid imaging in the diagnosis of neurodegenerative diseases
Frisoni, G. B., & Giannakopoulos, P. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.09.007 · Cited by 3
Metadata
- Authors
- Jack, C. R., Lowe, V. J., Weigand, S. D., Wiste, H. J., Senjem, M. L., Knopman, D. S., Shiung, M. M., Gunter, J. L., Boeve, B. F., Kemp, B. J., Weiner, M., & Petersen, R. C.
- Affiliations
- Mayo Clinic (US)
- San Francisco VA Medical Center (US)
- Corresponding author
- Jack, Clifford R.
- ORCID
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-03-31
- Volume
- 132
- Issue
- 5
- Pages
- 1355-1365
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC2677798
- OpenAlex
- W2133719476
- Cited by
- 1,099
- References
- 83
- Citations by year
- 2026: 29 · 2025: 28 · 2024: 34 · 2023: 51 · 2022: 45 · 2021: 49 · 2020: 60 · 2019: 54 · 2018: 62 · 2017: 46 · 2016: 56 · 2015: 69 · 2014: 73 · 2013: 94 · 2012: 116
- FWCI
- 71.53
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Brain (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Mayo Foundation for Medical Education and Research (AG16574)
- National Institute for Health and Care Research (NF-SI-0508-10123)
- National Institute on Aging (R01AG11378, P01AG010491, P50‐AG16574, U01AG06786, AG 024904, R01AG027342, U01AG006786, R01AG011378, P30AG019610, U19AG010483, P50AG016574)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- Alzheimer's disease, mild cognitive impairment, amyloid deposition, neurodegeneration, brain atrophy, ventriculomegaly, Pittsburgh compound B PET, serial imaging, amyloid plaques, cognitive decline, Alzheimer's Disease Neuroimaging Initiative, brain atrophy rate
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Aniline Compounds, Atrophy, Brain, Carbon Radioisotopes, Cognition Disorders, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Thiazoles, Time Factors, Case-Control Studies, Amyloid beta-Peptides, Statistics, Nonparametric, Radiopharmaceuticals, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.